TamikoRobinKatsumotoMDDipABLM
Rheumatology • Stanford, CAScleroderma & Related
Clinical Associate Professor
Dr. Katsumoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Tamiko Katsumoto is a rheumatologist based in Stanford, CA, specializing in scleroderma and related conditions. She earned her medical degree from the University of California San Francisco School of Medicine in 2002, followed by a residency in Internal Medicine and a fellowship in Rheumatology at the same institution. Currently, she serves as the Medical Director at Genentech, where she has worked since 2013. Her expertise includes interstitial lung disease, clinical trials in scleroderma, and the molecular mechanisms of fibrosis. Dr. Katsumoto has published several articles on topics such as immune checkpoint inhibitor-induced inflammatory arthritis and the impact of immunosuppressive agents in cancer therapy. She has been recognized as a Fellow of the American College of Rheumatology and received the CMS Meaningful Use Stage 1 Certification.
Education & Training
University of California (San Francisco)Fellowship, Rheumatology, 2005 - 2008- University of California (San Francisco)Residency, Internal Medicine, 2002 - 2005
- University of California San Francisco School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- Belumosudil in diffuse cutaneous systemic sclerosis: a randomised, double-blind, open-label extension, placebo-controlled, Phase 2 study.Lorinda Chung, Richard M Silver, Virginia Steen, Daniel E Furst, Flavia V Castelino
Rheumatology. 2025-03-14 - 1 citationsMimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis.José A Gómez-Puerta, Karolina Gente, Tamiko R Katsumoto, Jan Leipe, Pankti Reid
Rheumatic Diseases Clinics of North America. 2024-05-01 - Aromatase inhibitor-induced arthralgia ameliorated by Mediterranean diet and active lifestyle guided by continuous glucose monitoring: a case report and review of the ...Kalin L Wilson, Richard E Grewelle, Tanya Gupta, Sun H Kim, Tamiko R Katsumoto
Frontiers in Oncology. 2024-01-01
Journal Articles
- Peripheral Blood B Cell Depletion After Rituximab and Complete Response in Lupus NephritisMatthew D Cascino, Jay Garg, Paul Brunetta, Tamiko R Katsumoto, Paul Brakeman, Brad Rovin, Leonard Dragone, Richard John Looney, Journal of the American Society of Nephrology
Press Mentions
Do Antirheumatic Drugs Increase the Risk of Cancer?March 3rd, 2025- Case Report: Voriconazole-Induced PeriostitisOctober 8th, 2024
An Exploration of Pharmacogenomics in Rheumatoid ArthritisJuly 19th, 2019
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
